BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2141366)

  • 1. Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease.
    Kishida H; Hata N; Kusama Y; Iwahara S; Sasaki Y; Mori N; Yasutake M; Koumi S; Takayama M; Munakata K
    Jpn Heart J; 1990 Mar; 31(2):135-43. PubMed ID: 2141366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasodilatory action after nicorandil: a quantitative angiographic study.
    Suryapranata H; Serruys PW
    Am J Cardiol; 1989 Jun; 63(21):80J-85J. PubMed ID: 2525332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary vasodilatory action after a single dose of nicorandil.
    Suryapranata H; Serruys PW; De Feyter PJ; Verdouw PD; Hugenholtz PG
    Am J Cardiol; 1988 Feb; 61(4):292-7. PubMed ID: 2963519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective and safe dose of intracoronary nicorandil in man.
    Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
    Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicorandil and cardiovascular performance in patients with coronary artery disease.
    Suryapranata H; MacLeod D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S45-51. PubMed ID: 1282175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
    Aizawa T; Ogasawara K; Kato K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
    Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilation in human coronary circulation.
    Nishikawa Y; Kanki H; Ogawa S
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):21-8. PubMed ID: 9676716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
    Suryapranata H
    Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
    Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
    Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
    Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
    Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and therapeutic effects of nicorandil.
    Kinoshita M; Sakai K
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic effects of single-dose nicorandil in coronary artery disease.
    Coltart DJ; Signy M
    Am J Cardiol; 1989 Jun; 63(21):34J-39J. PubMed ID: 2525323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanism.
    Nakae I; Matsumoto T; Horie H; Yokohama H; Omura T; Minai K; Matsui T; Nozawa M; Takahashi M; Sugimoto Y; Ito M; Izumi M; Nakamura Y; Mitsunami K; Kinoshita M
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):919-25. PubMed ID: 10836727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic effects of nicorandil in coronary artery disease.
    Treese N; Erbel R; Meyer J
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S52-6. PubMed ID: 1282176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain.
    Arnold JM; Kowey PR; Wolf DL; Jungbluth GL; Hearron AE; Luderer JR
    Int J Cardiol; 1994 May; 44(3):203-15. PubMed ID: 8077066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction.
    Yokota M; Horisawa T; Iwase M; Miyahara T; Yoshida J; Kamihara S; Noda S; Tsunekawa A; Koide M; Tsuzuki M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S116-22. PubMed ID: 2447418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
    Sakaino N; Araki H; Nishi K
    Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of nicorandil on cardiovascular hemodynamics and left ventricular function.
    Kambara H; Nakamura Y; Tamaki S; Kawai C
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S104-8. PubMed ID: 2447416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
    Kato K
    Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.